NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

GAS5 Gene Expression and IL-6 in Rheumatoid Arthritis

Not Yet RecruitingN/A

Sponsor: Sohag University

Conditions: RA - Rheumatoid Arthritis

This study aims to investigate the expression of Growth Arrest-Specific 5 (GAS5) , a long non-coding RNA , in patients with Rheumatoid Arthritis compared with healthy individuals. The study will also assess the level of Interlukin-6 (IL-6) in the blood and explore the relationship between GAS5 expression and IL-6 levels in Rheumatoid Arthritis

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Adult patients older than 18 years patients diagnosed with Rheumatoid Arthritis according to the 2010 American collage Rheumatology / European League against Rheumatism (ACR/EULAR) classification criteria

Exclusion Criteria:

* Patients who did not meet the previous inclusion criteria